Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3168 | 1642 | 36.2 | 77% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
17846 | 516 | THY 1//THY 1 CD90//ANTI THY 1 ANTIBODY |
18944 | 463 | MAL DE MELEDA//TEX101//SLURP 1 |
21180 | 370 | NDRG2//NDRG1//N MYC DOWNSTREAM REGULATED GENE 1 |
23383 | 293 | CD24//HEAT STABLE ANTIGEN//INTEGRATED CANC PREVENT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CD24 | Author keyword | 80 | 51% | 7% | 113 |
2 | NDRG2 | Author keyword | 78 | 81% | 3% | 47 |
3 | NDRG1 | Author keyword | 58 | 68% | 3% | 50 |
4 | MAL DE MELEDA | Author keyword | 30 | 84% | 1% | 16 |
5 | N MYC DOWNSTREAM REGULATED GENE 2 | Author keyword | 29 | 88% | 1% | 14 |
6 | N MYC DOWNSTREAM REGULATED GENE 1 | Author keyword | 24 | 82% | 1% | 14 |
7 | TEX101 | Author keyword | 21 | 85% | 1% | 11 |
8 | THY 1 | Author keyword | 19 | 31% | 3% | 51 |
9 | CAP43 | Author keyword | 17 | 79% | 1% | 11 |
10 | SLURP 1 | Author keyword | 17 | 75% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD24 | 80 | 51% | 7% | 113 | Search CD24 | Search CD24 |
2 | NDRG2 | 78 | 81% | 3% | 47 | Search NDRG2 | Search NDRG2 |
3 | NDRG1 | 58 | 68% | 3% | 50 | Search NDRG1 | Search NDRG1 |
4 | MAL DE MELEDA | 30 | 84% | 1% | 16 | Search MAL+DE+MELEDA | Search MAL+DE+MELEDA |
5 | N MYC DOWNSTREAM REGULATED GENE 2 | 29 | 88% | 1% | 14 | Search N+MYC+DOWNSTREAM+REGULATED+GENE+2 | Search N+MYC+DOWNSTREAM+REGULATED+GENE+2 |
6 | N MYC DOWNSTREAM REGULATED GENE 1 | 24 | 82% | 1% | 14 | Search N+MYC+DOWNSTREAM+REGULATED+GENE+1 | Search N+MYC+DOWNSTREAM+REGULATED+GENE+1 |
7 | TEX101 | 21 | 85% | 1% | 11 | Search TEX101 | Search TEX101 |
8 | THY 1 | 19 | 31% | 3% | 51 | Search THY+1 | Search THY+1 |
9 | CAP43 | 17 | 79% | 1% | 11 | Search CAP43 | Search CAP43 |
10 | SLURP 1 | 17 | 75% | 1% | 12 | Search SLURP+1 | Search SLURP+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DOWNSTREAM REGULATED GENE 2 | 99 | 91% | 2% | 41 |
2 | DRG 1 | 93 | 100% | 2% | 28 |
3 | HEAT STABLE ANTIGEN | 49 | 46% | 5% | 80 |
4 | NDRG1 | 41 | 85% | 1% | 22 |
5 | DIFFERENTIATION RELATED GENE | 41 | 100% | 1% | 15 |
6 | MOUSE CD24 | 29 | 88% | 1% | 14 |
7 | GENE ENCODING SLURP 1 | 24 | 91% | 1% | 10 |
8 | DE MELEDA | 23 | 86% | 1% | 12 |
9 | THYMIC SHARED ANTIGEN 1 | 21 | 69% | 1% | 18 |
10 | ANTIGEN CD24 | 20 | 100% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications | 2010 | 63 | 104 | 77% |
Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy | 2014 | 8 | 281 | 48% |
Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis | 2006 | 117 | 89 | 65% |
Ly6 family proteins in neutrophil biology | 2013 | 19 | 96 | 43% |
CD24: from A to Z | 2010 | 25 | 99 | 73% |
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states | 2008 | 82 | 69 | 38% |
TISSUE EXPRESSION, STRUCTURE AND FUNCTION OF THE MURINE LY-6 FAMILY OF MOLECULES | 1995 | 120 | 97 | 58% |
NDRG2: a Myc-repressed gene involved in cancer and cell stress | 2008 | 29 | 79 | 78% |
Concise review: Stem cell antigen-1: Expression, function, and enigma | 2007 | 152 | 115 | 28% |
The role of NDRG1 in the pathology and potential treatment of human cancers | 2013 | 5 | 83 | 66% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTEGRATED CANC PREVENT | 3 | 22% | 0.8% | 13 |
2 | PHARMACEUT ONCOL | 2 | 20% | 0.6% | 10 |
3 | TRADIT CHINESE WESTERN MED ONCOL | 2 | 50% | 0.2% | 3 |
4 | MOL PHARMACOL PATHOL PROGRAM | 2 | 19% | 0.4% | 7 |
5 | GENERY SURG | 1 | 50% | 0.1% | 2 |
6 | MOL IMMUNOGENET TRANSPLANTAT | 1 | 100% | 0.1% | 2 |
7 | EUCARYOT CELL BIOL GRP | 1 | 40% | 0.1% | 2 |
8 | NUCLEO OIO AO PESQUISADOR | 1 | 40% | 0.1% | 2 |
9 | MED BACTERIOL SHOWA KU | 1 | 33% | 0.1% | 2 |
10 | MED IMMUNOL SHOWA KU | 1 | 33% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000017246 | THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR |
2 | 0.0000015310 | AGR2//ALCAM//GICERIN |
3 | 0.0000011237 | TENASCIN C//TENASCIN//POLYSIALIC ACID |
4 | 0.0000010976 | INSULIN DEGRADING ENZYME//GLYCOSYLPHOSPHATIDYLINOSITOL//NEPRILYSIN |
5 | 0.0000009563 | CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA |
6 | 0.0000008052 | CANCER STEM CELLS//CD133//ADULT NEUROGENESIS |
7 | 0.0000007559 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
8 | 0.0000007018 | TISSUE ANTIGENS//IMMUNOGENETICS//HUMAN IMMUNOLOGY |
9 | 0.0000006943 | NON NEURONAL ACETYLCHOLINE//CHOLINERGIC ANTI INFLAMMATORY PATHWAY//HEMICHOLINIUM 3 |
10 | 0.0000006729 | EZRIN//MOESIN//RADIXIN |